Cancer BiologybioRxiv
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
D. Memon, H. Rizvi, G. Fromm…·M. D. Hellmann
This study characterizes clinical and molecular features of acquired resistance to PD-(L)1 blockade in NSCLC, identifying persistent inflammation and dysfunctional IFN signaling as key features.
DOI 10.1016/j.ccell.2023.12.013